Astellas: An Open-Label, Multicenter, Multi-Cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202):
Bayer : An open-label, multi-center, phase 1b/2 study to evaluate thesafety and efficacy of copanlisib in combination with nivolumabin patients with advanced solid tumors:
Lilly: J2K-MC-JZKA: A Phase 1/2 Study of LY3499446 Administered to Patients with AdvancedSolid Tumors with KRAS G12C mutation:"
Mirati phase 1/2 (Basket) - A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation:
For more information about Beverly Hills Cancer Center's comprehensive clinical research programs and trials currently available to patients, please contact us at (310) 432-8932 or click here to send in an inquiry.
To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or Click the link below to access our Online Appointment Request
Book An Appointment© Beverly Hills Cancer Center. All Rights Reserved. Web Design & Internet Marketing by Studio III
